Many bacterial pathogens promote infection and cause disease by directly injecting into host cells proteins that manipulate eukaryotic cellular processes. Identification of these translocated proteins is essential to understanding pathogenesis. Yet, their identification remains limited. This, in part, is due to their general sequence uniqueness, which confounds homology-based identification by comparative genomic methods. In addition, their absence often does not result in phenotypes in virulence assays limiting functional genetic screens. Translocated proteins have been observed to confer toxic phenotypes when expressed in the yeast Saccharomyces cerevisiae. This observation suggests that yeast growth inhibition can be used as an indicator of protein translocation in functional genomic screens. However, limited information is available regarding the behavior of non-translocated proteins in yeast. We developed a semi-automated quantitative assay to monitor the growth of hundreds of yeast strains in parallel. We observed that expression of half of the 19 Shigella translocated proteins tested but almost none of the 20 non-translocated Shigella proteins nor ~1,000 Francisella tularensis proteins significantly inhibited yeast growth. Not only does this study establish that yeast growth inhibition is a sensitive and specific indicator of translocated proteins, but we also identified a new substrate of the Shigella type III secretion system (TTSS), IpaJ, previously missed by other experimental approaches. In those cases where the mechanisms of action of the translocated proteins are known, significant yeast growth inhibition correlated with the targeting of conserved cellular processes. By providing positive rather than negative indication of activity our assay complements existing approaches for identification of translocated proteins. In addition, because this assay only requires genomic DNA it is particularly valuable for studying pathogens that are difficult to genetically manipulate or dangerous to culture.
References
[1]
Galán JE, Collmer A (1999) Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284: 1322–1328.
[2]
Hueck CJ (1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62: 379–433.
[3]
Sexton JA, Vogel JP (2002) Type IVB secretion by intracellular pathogens. Traffic 3: 178–185.
[4]
Saenz HL, Dehio C (2005) Signature-tagged mutagenesis: technical advances in a negative selection method for virulence gene identification. Curr Opin Microbiol 8: 612–619.
[5]
Valdivia RH, Falkow S (1997) Fluorescence-based isolation of bacterial genes expressed within host cells. Science 277: 2007–2011.
[6]
Zhou D, Galan J (2001) Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbes Infect 3: 1293–1298.
[7]
Lesser CF, Miller SI (2001) Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. Embo J 20: 1840–1849.
[8]
Campodonico EM, Chesnel L, Roy CR (2005) A yeast genetic system for the identification and characterization of substrate proteins transferred into host cells by the Legionella pneumophila Dot/Icm system. Mol Microbiol 56: 918–933.
[9]
Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, et al. (2003) The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. Embo J 22: 2959–2969.
[10]
Shohdy N, Efe JA, Emr SD, Shuman HA (2005) Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking. Proc Natl Acad Sci U S A 102: 4866–4871.
[11]
Von Pawel-Rammingen U, Telepnev MV, Schmidt G, Aktories K, Wolf-Watz H, et al. (2000) GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol 36: 737–748.
[12]
Yoon S, Liu Z, Eyobo Y, Orth K (2003) Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism. J Biol Chem 278: 2131–2135.
[13]
Hassane DC, Lee RB, Mendenhall MD, Pickett CL (2001) Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect Immun 69: 5752–5759.
[14]
Rodriguez-Escudero I, Hardwidge PR, Nombela C, Cid VJ, Finlay BB, et al. (2005) Enteropathogenic Escherichia coli type III effectors alter cytoskeletal function and signalling in Saccharomyces cerevisiae. Microbiology 151: 2933–2945.
[15]
Cossart P, Sansonetti PJ (2004) Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304: 242–248.
[16]
Buchrieser C, Glaser P, Rusniok C, Nedjari H, D'Hauteville H, et al. (2000) The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol Microbiol 38: 760–771.
[17]
Venkatesan MM, Goldberg MB, Rose DJ, Grotbeck EJ, Burland V, et al. (2001) Complete DNA sequence and analysis of the large virulence plasmid of Shigella flexneri. Infect Immun 69: 3271–3285.
[18]
Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, et al. (2002) Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology. Embo J 21: 5069–5078.
[19]
Tran Van Nhieu G, Caron E, Hall A, Sansonetti PJ (1999) IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. Embo J 18: 3249–3262.
[20]
Toyotome T, Suzuki T, Kuwae A, Nonaka T, Fukuda H, et al. (2001) Shigella protein IpaH(9.8) is secreted from bacteria within mammalian cells and transported to the nucleus. J Biol Chem 276: 32071–32079.
[21]
Yoshida S, Katayama E, Kuwae A, Mimuro H, Suzuki T, et al. (2002) Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. Embo J 21: 2923–2935.
[22]
Ogawa M, Suzuki T, Tatsuno I, Abe H, Sasakawa C (2003) IcsB, secreted via the type III secretion system, is chaperoned by IpgA and required at the post-invasion stage of Shigella pathogenicity. Mol Microbiol 48: 913–931.
[23]
Ohya K, Handa Y, Ogawa M, Suzuki M, Sasakawa C (2005) IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells: Its activity to promote membrane ruffling via RAC1 and CDC42 activation. J Biol Chem.
[24]
Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D (2004) Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 68: 692–744.
[25]
Warringer J, Blomberg A (2003) Automated screening in environmental arrays allows analysis of quantitative phenotypic profiles in Saccharomyces cerevisiae. Yeast 20: 53–67.
[26]
Belli G, Gari E, Piedrafita L, Aldea M, Herrero E (1998) An activator/repressor dual system allows tight tetracycline-regulated gene expression in budding yeast. Nucleic Acids Res 26: 942–947.
[27]
Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, et al. (2007) An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 8: 47–56.
[28]
Kramer RW, Slagowski NL, Eze NA, Giddings KS, Morrison MF, et al. (2007) Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog 3: e21. doi: 10.1371/journal.ppat.0030021.
[29]
Li H, Xu H, Zhou Y, Zhang J, Long C, et al. (2007) The phosphothreonine lyase activity of a bacterial type III effector family. Science 315: 1000–1003.
[30]
Alto NM, Shao F, Lazar CS, Brost RL, Chua G, et al. (2006) Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124: 133–145.
[31]
Tran Van Nhieu G, Ben-Ze'ev A, Sansonetti PJ (1997) Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. Embo J 16: 2717–2729.
[32]
Sayeed S, Reaves L, Radnedge L, Austin S (2000) The stability region of the large virulence plasmid of Shigella flexneri encodes an efficient postsegregational killing system. J Bacteriol 182: 2416–2421.
[33]
Picardeau M, Le Dantec C, Richard GF, Saint Girons I (2003) The spirochetal chpK-chromosomal toxin-antitoxin locus induces growth inhibition of yeast and mycobacteria. FEMS Microbiol Lett 229: 277–281.
[34]
Kristoffersen P, Jensen GB, Gerdes K, Piskur J (2000) Bacterial toxin-antitoxin gene system as containment control in yeast cells. Appl Environ Microbiol 66: 5524–5526.
[35]
Leonard TA, Butler PJ, Lowe J (2005) Bacterial chromosome segregation: structure and DNA binding of the Soj dimer–a conserved biological switch. Embo J 24: 270–282.
[36]
Gachotte D, Pierson CA, Lees ND, Barbuch R, Koegel C, et al. (1997) A yeast sterol auxotroph (erg25) is rescued by addition of azole antifungals and reduced levels of heme. Proc Natl Acad Sci U S A 94: 11173–11178.
[37]
Zuo D, Mohr SE, Hu Y, Taycher E, Rolfs A, et al. (2007) PlasmID: a centralized repository for plasmid clone information and distribution. Nucleic Acids Res 35: D680–D684.
[38]
Marsischky G, LaBaer J (2004) Many paths to many clones: a comparative look at high-throughput cloning methods. Genome Res 14: 2020–2028.
[39]
Larsson P, Oyston PC, Chain P, Chu MC, Duffield M, et al. (2005) The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet 37: 153–159.
[40]
Gallagher LA, Ramage E, Jacobs MA, Kaul R, Brittnacher M, et al. (2007) A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc Natl Acad Sci U S A 104: 1009–1014.
[41]
Forsberg A, Guina T (2007) Type II secretion and type IV pili of Francisella. Ann N Y Acad Sci 1105: 187–201.
[42]
Hager AJ, Bolton DL, Pelletier MR, Brittnacher MJ, Gallagher LA, et al. (2006) Type IV pili-mediated secretion modulates Francisella virulence. Mol Microbiol 62: 227–237.
[43]
Barker JR, Klose KE (2007) Molecular and genetic basis of pathogenesis in Francisella tularensis. Ann N Y Acad Sci 1105: 138–159.
[44]
Nano FE, Schmerk C (2007) The Francisella pathogenicity island. Ann N Y Acad Sci 1105: 122–137.
[45]
Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, et al. (2006) Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A 103: 1528–1533.
[46]
Dudley AM, Janse DM, Tanay A, Shamir R, Church GM (2005) A global view of pleiotropy and phenotypically derived gene function in yeast. Mol Syst Biol. doi: 10.1038/msb4100004.
[47]
Parsons AB, Brost RL, Ding H, Li Z, Zhang C, et al. (2004) Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 22: 62–69.
[48]
Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, et al. (2004) Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci U S A 101: 793–798.
[49]
March JC, Rao G, Bentley WE (2003) Biotechnological applications of green fluorescent protein. Appl Microbiol Biotechnol 62: 303–315.
[50]
Schuch R, Sandlin RC, Maurelli AT (1999) A system for identifying post-invasion functions of invasion genes: requirements for the Mxi-Spa type III secretion pathway of Shigella flexneri in intercellular dissemination. Mol Microbiol 34: 675–689.
[51]
Bahrani FK, Sansonetti PJ, Parsot C (1997) Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation. Infect Immun 65: 4005–4010.
[52]
Labaer J, Qiu Q, Anumanthan A, Mar W, Zuo D, et al. (2004) The Pseudomonas aeruginosa PA01 gene collection. Genome Res 14: 2190–2200.
[53]
Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C (2007) Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 1: 77–83.
[54]
Clerc P, Sansonetti PJ (1987) Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun 55: 2681–2688.
[55]
Team RDC (2004) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
[56]
Suzuki T, Miki H, Takenawa T, Sasakawa C (1998) Neural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneri. Embo J 17: 2767–2776.
[57]
Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, et al. (2005) Escape of intracellular Shigella from autophagy. Science 307: 727–731.
[58]
Tran Van Nhieu G, Ben-Ze'ev A, Sansonetti PJ (1997) Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. Embo J 16: 2717–2729.
[59]
Handa Y, Suzuki M, Ohya K, Iwai H, Ishijima N, et al. (2007) Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery. Nat Cell Biol 9: 121–128.
[60]
Yoshida S, Handa Y, Suzuki T, Ogawa M, Suzuki M, et al. (2006) Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science 314: 985–989.
